Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2018

Open Access 01-12-2018 | Study protocol

A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial

Authors: M. Deady, D. A. Johnston, N. Glozier, D. Milne, I. Choi, A. Mackinnon, A. Mykletun, R. A. Calvo, A. Gayed, R. Bryant, H. Christensen, S. B. Harvey

Published in: BMC Psychiatry | Issue 1/2018

Login to get access

Abstract

Background

Depression is a commonly occurring disorder linked to diminished role functioning and quality of life. The development of treatments that overcome barriers to accessing treatment remains an important area of clinical research as most people delay or do not receive treatment at an appropriate time. The workplace is an ideal setting to roll-out an intervention, particularly given the substantial psychological benefits associated with remaining in the workforce. Mobile health (mhealth) interventions utilising smartphone applications (apps) offer novel solutions to disseminating evidence based programs, however few apps have undergone rigorous testing. The present study aims to evaluate the effectiveness of a smartphone app designed to treat depressive symptoms in workers.

Methods

The present study is a multicentre randomised controlled trial (RCT), comparing the effectiveness of the intervention to that of an attention control. The primary outcome measured will be reduced depressive symptoms at 3 months. Secondary outcomes such as wellbeing and work performance will also be measured. Employees from a range of industries will be recruited via a mixture of targeted social media advertising and Industry partners. Participants will be included if they present with likely current depression at baseline. Following baseline assessment (administered within the app), participants will be randomised to receive one of two versions of the Headgear application: 1) Intervention (a 30-day mental health intervention focusing on behavioural activation and mindfulness), or 2) attention control app (mood monitoring for 30 days). Participants will be blinded to their allocation. Analyses will be conducted within an intention to treat framework using mixed modelling.

Discussion

The results of this trial will provide valuable information about the effectiveness of mhealth interventions in the treatment of depressive symptoms in a workplace context.

Trial registration

The current trial is registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12617000547​347, Registration date: 19/04/2017).
Literature
1.
Organization, W.H., Depression and other common mental disorders: global health estimates. 2017.
2.
Slade T, et al. 2007 National Survey of mental health and wellbeing: methods and key findings. Aust N Z J Psychiatry. 2009;43(7):594–605.CrossRefPubMed
3.
Harvey SB, et al. Depression and work performance: an ecological study using web-based screening. Occup Med (Lond). 2011;61(3):209–11.CrossRef
4.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC: APA; 2013.CrossRef
5.
Kessler RC, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003;289(23):3095–105.CrossRefPubMed
6.
Harvey SB, et al. Is the prevalence of mental illness increasing in Australia? Evidence from national health surveys and administrative data, 2001–2014. Med J Aust. 2017;206(11):490–3.CrossRefPubMed
7.
8.
Cuijpers P, et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909–22.
9.
Butler AC, et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17–31.CrossRefPubMed
10.
Richards DA, et al. Cost and outcome of Behavioural activation versus cognitive Behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 2016;388(10047):871–80.CrossRefPubMedPubMedCentral
11.
Olfson M, Marcus SC. National trends in outpatient psychotherapy. Am J Psychiatr. 2010;167(12):1456–63.CrossRefPubMed
12.
Mohr DC, et al. Barriers to psychotherapy among depressed and nondepressed primary care patients. Ann Behav Med. 2006;32(3):254–8.CrossRefPubMed
13.
Sanderson K, Andrews G. Common mental disorders in the workforce: recent findings from descriptive and social epidemiology. Can J Psychiatry. 2006;51(2):63–75.CrossRefPubMed
14.
Modini M, et al. The mental health benefits of employment: results of a systematic meta-review. Australas Psychiatry. 2016;24(4):331–6.CrossRefPubMed
15.
Tan L, et al. Preventing the development of depression at work: a systematic review and meta-analysis of universal interventions in the workplace. BMC Med. 2014;12(1):74.CrossRefPubMedPubMedCentral
16.
Joyce S, et al. Workplace interventions for common mental disorders: a systematic meta-review. Psychol Med. 2016;46(4):683–97.
17.
18.
Roche AM, et al. Men, work, and mental health: a systematic review of depression in male-dominated industries and occupations. Safety and health at work. 2016;7(4):268–83.CrossRefPubMedPubMedCentral
19.
Deady M, et al. Designing smartphone mental health applications for emergency service workers. Occup Med. 2017:kqx056.
20.
Donker T, et al. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res. 2013;15(11):e247.
21.
Calvo RA, et al. Computing in mental health. In: Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems. San Jose: ACM; 2016.
22.
Josephine K, et al. Internet-and mobile-based depression interventions for people with diagnosed depression: a systematic review and meta-analysis. J Affect Disord. 2017;223:28–40.CrossRefPubMed
23.
Calvo R, et al. Positive computing: a new partnership between psychology, social sciences and technologists (editorial introduction), vol. 6; 2016.
24.
Reynolds S. Psychological well-being at work: is prevention better than cure? J Psychosom Res. 1997;43(1):93–102.CrossRefPubMed
25.
Association, W.M. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191–4.CrossRef
26.
27.
Australian Bureau of Statistics. Australian and New Zealand standard industrial classification. Canberra: Australian Bureau of Statistics; 2008.
28.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–15.CrossRef
29.
Choi I, et al. Using different Facebook advertisements to recruit men for an online mental health study: engagement and selection bias. Internet Interventions. 2017;8:27–34.CrossRefPubMedPubMedCentral
30.
31.
Hopko DR, et al. Contemporary behavioral activation treatments for depression: procedures, principles, and progress. Clin Psychol Rev. 2003;23(5):699–717.CrossRefPubMed
32.
Lejuez CW, et al. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif. 2011;35(2):111–61.CrossRefPubMed
33.
Richards DA, et al. Cost and outcome of Behavioural activation versus cognitive Behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 388(10047):871–80.
34.
Ly KH, et al. Behavioural activation versus mindfulness-based guided self-help treatment administered through a smartphone application: a randomised controlled trial. BMJ Open. 2014;4(1):e003440.CrossRefPubMedPubMedCentral
35.
Brown KW, Ryan RM, Creswell JD. Mindfulness: theoretical foundations and evidence for its salutary effects. Psychol Inq. 2007;18(4):211–37.CrossRef
36.
Greeson J, Garland EL, Black D. Mindfulness: a transtherapeutic approach for transdiagnostic mental processes. Wiley Blackwell handbook of mindfulness. 2014:531–62.
37.
38.
39.
Titov N, et al. Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: randomised controlled trial. PLoS One. 2013;8(7):e62873.CrossRefPubMedPubMedCentral
40.
Matthews M, et al. Designing mobile applications to support mental health interventions. In: Jo L, editor. Handbook of Research on User Interface Design and Evaluation for Mobile Technology. London: IGI, Information Science Reference; 2008. p. 635–56.
41.
42.
Deady M, et al. Designing smartphone mental health applications for emergency service workers. Occup Med. 2017;
43.
Calvo RA, Peters D. Positive computing: technology for wellbeing and human potential. Cambridge: MIT Press; 2014.
44.
45.
Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter. 2004;32:15–6.
46.
Bech P, Gudex C, Staehr Johansen K. The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom. 1996;65:183–90.CrossRefPubMed
47.
Kroenke K, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317–25.CrossRefPubMed
48.
Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson resilience scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82.CrossRefPubMed
49.
Kessler RC, et al. The world health organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45(2):156–74.CrossRefPubMed
50.
Spitzer RL, et al. Validation and utility of a self-report version of PRIME-MD - the PHQ primary care study. JAMA. 1999;282(18):1737–44.CrossRefPubMed
51.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA. 1999;282(18):1737–44.CrossRefPubMed
52.
53.
Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the connor–Davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress. 2007;20(6):1019–28.CrossRefPubMed
54.
Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol. 2005;1:255–91.CrossRefPubMed
55.
Krieger T, et al. Measuring depression with a well-being index: further evidence for the validity of the WHO well-being index (WHO-5) as a measure of the severity of depression. J Affect Disord. 2014;156:240–4.CrossRefPubMed
56.
Imamura KKNF, Matsuyama Yutaka TA, Akihito S, Rino U, Sonoko K, Kiyoto K. Effects of an internet-based cognitive behavioral therapy (iCBT) program in manga format on improving subthreshold depressive symptoms among healthy workers: a randomized controlled trial. PLoS One. 2014;9(5):e97167.CrossRefPubMedPubMedCentral
57.
Johnson PO, Neyman J. Tests of certain linear hypotheses and their application to some educational problems. Stat Res Memoir. 1936;1:57–93.
58.
Green P, MacLeod CJ, SIMR. An R package for power analysis of generalized linear mixed models by simulation. Methods Ecol Evol. 2016;7(4):493–8.CrossRef
59.
Lerner D, Henke RM. What does research tell us about depression, job performance, and work productivity? J Occup Environ Med. 2008;50(4):401–10.CrossRefPubMed
60.
Wang PS, et al. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629–40.CrossRefPubMed
61.
Whiteford HA, et al. The work outcomes research cost-benefit (WORC) project: the return on investment for facilitating help seeking behaviour. Aust N Z J Psychiatry. 2005;39:A37.
62.
Hanisch SE, et al. The effectiveness of interventions targeting the stigma of mental illness at the workplace: a systematic review. BMC Psychiatry. 2016;16(1):1.CrossRefPubMedPubMedCentral
63.
French MT, et al. Factors that influence the use and perceptions of employee assistance programs at six worksites. J Occup Health Psychol. 1997;2(4):312.CrossRefPubMed
64.
Leykin Y, et al. Results from a trial of an unsupported internet intervention for depressive symptoms. Internet Interventions. 2014;1(4):175–81.CrossRefPubMed
65.
Donker T, et al. Internet-delivered interpersonal psychotherapy versus internet-delivered cognitive behavioral therapy for adults with depressive symptoms: randomized controlled noninferiority trial. J Med Internet Res. 2013;15:e82.CrossRefPubMedPubMedCentral
66.
De Maat S, et al. Relative efficacy of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Psychother Res. 2006;16(5):566–78.CrossRef
67.
Christensen H, et al. Free range users and one hit wonders: community users of an internet-based cognitive behaviour therapy program. Aust N Z J Psychiatry. 2006;40(1):59–62.CrossRefPubMed
68.
Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012;184(3):E191–6.CrossRef
69.
Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the patient health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37(1):67–75.CrossRefPubMed
Metadata
Title
A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial
Authors
M. Deady
D. A. Johnston
N. Glozier
D. Milne
I. Choi
A. Mackinnon
A. Mykletun
R. A. Calvo
A. Gayed
R. Bryant
H. Christensen
S. B. Harvey
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2018
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-018-1752-5

Other articles of this Issue 1/2018

BMC Psychiatry 1/2018 Go to the issue

Research article

Meaningful connections in dementia end of life care in long term care homes

Study protocol

Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial

Study protocol

Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy

Study protocol

Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial

Research article

Prevalence of depression or depressive symptoms among people living with HIV/AIDS in China: a systematic review and meta-analysis

Research article

Novel online daily diary interventions for nonsuicidal self-injury: a randomized controlled trial